Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201310013 Principal Investigator: Wagner-Johnston, Nina
Title: An Open-Label, Phase I, Dose-Escalation Study Evaluating the Safety and Tolerability of GDC-0853 in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma and Chronic Lymphocytic Leukemia
Phase: I Disease Site: Hodgkin's Lymphoma
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The purpose of this study is to test the safety of an experimental drug (GDC-0853, the study drug) to determine a safe and tolerated dose, how often it should be taken, how well patients with cancer can tolerate this experimental drug, and measure how your body processes the study drug at different dose levels. We want to find out what effects, good and/or bad, it has on you and your cancer.
 
More Information:
clinicaltrials.gov link
Internal Protocol Documents (requires Siteman administrative database password)